16-84145553-G-C
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 2P and 16B. PM2BP4_StrongBP6_Very_StrongBS1
The NM_178452.6(DNAAF1):āc.113G>Cā(p.Gly38Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000205 in 1,548,642 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ).
Frequency
Consequence
NM_178452.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DNAAF1 | NM_178452.6 | c.113G>C | p.Gly38Ala | missense_variant | 1/12 | ENST00000378553.10 | NP_848547.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DNAAF1 | ENST00000378553.10 | c.113G>C | p.Gly38Ala | missense_variant | 1/12 | 1 | NM_178452.6 | ENSP00000367815.5 | ||
DNAAF1 | ENST00000567918.5 | n.113G>C | non_coding_transcript_exon_variant | 1/7 | 1 | ENSP00000455154.1 | ||||
DNAAF1 | ENST00000563093.5 | n.113G>C | non_coding_transcript_exon_variant | 1/11 | 2 | ENSP00000457373.1 | ||||
DNAAF1 | ENST00000570298.5 | n.267G>C | non_coding_transcript_exon_variant | 1/11 | 2 |
Frequencies
GnomAD3 genomes AF: 0.00109 AC: 166AN: 152210Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000159 AC: 24AN: 150542Hom.: 0 AF XY: 0.000113 AC XY: 9AN XY: 79908
GnomAD4 exome AF: 0.000108 AC: 151AN: 1396314Hom.: 1 Cov.: 31 AF XY: 0.0000886 AC XY: 61AN XY: 688844
GnomAD4 genome AF: 0.00110 AC: 167AN: 152328Hom.: 0 Cov.: 32 AF XY: 0.000980 AC XY: 73AN XY: 74482
ClinVar
Submissions by phenotype
Primary ciliary dyskinesia Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 25, 2023 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 16, 2018 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
DNAAF1-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jul 06, 2022 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at